Roth Capital Has Bullish Outlook for CVE:HIV FY2025 Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Stock analysts at Roth Capital lifted their FY2025 earnings per share estimates for shares of HIVE Blockchain Technologies in a research report issued to clients and investors on Wednesday, January 8th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings per share of ($0.53) for the year, up from their previous estimate of ($0.54). Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.10) EPS, Q1 2026 earnings at ($0.09) EPS, Q3 2026 earnings at ($0.09) EPS, FY2026 earnings at ($0.16) EPS and FY2028 earnings at ($0.09) EPS.

HIV has been the topic of a number of other reports. Northland Capmk upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th. Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. Finally, Keefe, Bruyette & Woods raised HIVE Blockchain Technologies to a “moderate buy” rating in a research report on Wednesday, January 8th. Four analysts have rated the stock with a strong buy rating, According to MarketBeat, the company presently has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.